Sustavit Okopnik c Mumijo
Sustavit Okopnik c Mumijo was recalled on 29 March 2019 under EU Safety Gate alert A12/0514/19. Chemical risk reported by Lithuania. According to the ingredients list, the product contains a mixture of the preservatives methylchloroisothiazolinone and methylisothiazolinone (MCI/MI), which is not permitted in leave-on cosmetic products.
| Alert Number | A12/0514/19 |
| Brand | Neogalen |
| Category | Cosmetics |
| Risk Type | Chemical |
| Notifying Country | Lithuania |
| Country of Origin | Russian Federation |
| Published | 29 March 2019 |
Risk Description
According to the ingredients list, the product contains a mixture of the preservatives methylchloroisothiazolinone and methylisothiazolinone (MCI/MI), which is not permitted in leave-on cosmetic products. Dermal contact with MCI and MI containing products can provoke allergic contact dermatitis to sensitised persons.The product does not comply with the Cosmetic Products Regulation.
Measures Taken
Type of economic operator to whom the measure(s) were ordered: ImporterCategory of measure(s): Withdrawal of the product from the marketDate of entry into force: 14/02/2019
Product Description
Tube containing 125 ml of cream against muscular and joint pain, sold in a cardboard box.
🧪 What Should You Do?
This recall involves a chemical hazard related to Sustavit Okopnik c Mumijo.
About this risk
This product contains prohibited or hazardous chemical substances that may cause skin irritation, allergic reactions, or long-term health effects.
Recommended action
Stop using the product immediately. Wash any skin that has come into contact with it. Keep it away from children. Return it to the retailer for a refund if possible.
Who is at risk?
Anyone who has used this product, especially children, pregnant women, and people with sensitive skin.